The FemTech Series: Analysing the risk of breast cancer recurrence
Posted in Medicine

The FemTech Series: Analysing the risk of breast cancer recurrence

Posted on
by admin

In this episode of The FemTech Series, you can hear Olivia Friett, editor of Medical Plastics News talk to Hemmel Amrania PhD, CEO of Digistain, a company that has won multiple awards for its transformative breast cancer biomarker analytics.

admin

You May Also Like

More From Author

Dolphins’ Tua Tagovailoa set to practice this week, return from concussion

Dolphins’ Tua Tagovailoa set to practice this week, return from concussion

Biglaw Firm Sets The Record Straight On Layoffs — See Also

Biglaw Firm Sets The Record Straight On Layoffs — See Also

Leave a Reply

Your email address will not be published. Required fields are marked *